Gynemedia Juillet 2022
L‘information et Suggestions de GYNEMED Edition de Juillet 2022
L‘information et Suggestions de GYNEMED Edition de Juillet 2022
Big News: We’re Growing!
Nexpring Health has completed the acquisition of Irvine Scientific’s ART and Cytogenetics
product lines, uniting media, consumables, capital equipment, and lab services under one trusted brand.
✅ Same trusted quality and support
✅ More connected solutions for your entire IVF workflow
✅ No disruption to your current ordering or service
We’re excited to bring even more value to embryologists, clinicians, and fertility clinics, because you’re at the center of everything we do.
Learn More About the Acquisition
Vous devez charger le contenu de reCAPTCHA pour soumettre le formulaire. Veuillez noter que ce faisant, des données seront partagées avec des providers tiers.
Plus d'informations